September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Utility of TGFBI screening in the diagnosis of suspected paraproteinemic keratopathy
Author Affiliations & Notes
  • Marina Zakharevich
    Stein Eye Institute, Los Angeles, California, United States
  • Tova Mannis
    University of California San Francisco, San Francisco, California, United States
  • Gabriel Mannis
    University of California San Francisco, San Francisco, California, United States
  • Jennifer Rose-Nussbaumer
    University of California San Francisco, San Francisco, California, United States
  • Anthony J Aldave
    Stein Eye Institute, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Marina Zakharevich, None; Tova Mannis, None; Gabriel Mannis, None; Jennifer Rose-Nussbaumer, None; Anthony Aldave, None
  • Footnotes
    Support  NEI Grant 1R01 EY022082 (A.J.A.), NEI Grant P30 EY000331 (core grant), the Walton Li Chair, the Stottr fund and an unrestricted grant from Research to Prevent Blindness
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2356. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Marina Zakharevich, Tova Mannis, Gabriel Mannis, Jennifer Rose-Nussbaumer, Anthony J Aldave; Utility of TGFBI screening in the diagnosis of suspected paraproteinemic keratopathy. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2356.

      Download citation file:


      © 2017 Association for Research in Vision and Ophthalmology.

      ×
  • Supplements
Abstract

Purpose : To describe the clinical utility of molecular genetic analysis in the diagnosis or exclusion of suspected corneal dystrophies.

Methods : Slit lamp examination and optical coherence tomography (OCT) were performed on a 52 year old female referred for evaluation of bilateral corneal stromal opacities. After informed consent was obtained, genomic DNA was collected, and PCR amplification and cycle sequencing of all 17 exons and exon-intron boundaries of TGFBI were performed.

Results : Slit lamp examination demonstrated bilateral discrete anterior stromal opacities, which were also demonstrated by OCT to be confined to a single plane in the anterior corneal stroma. While the appearance of the opacities was consistent with granular corneal dystrophy, they were located in only the temporal cornea in a crescentic pattern, sparing the central cornea. This pattern, the late onset and the absence of a family history were atypical of GCD. Screening of TGFBI did not reveal a pathogenic mutation, excluding GCD1 and other TGFBI-related corneal dystrophies as the cause of the observed corneal phenotype. The patient was subsequently referred for evaluation to exclude paraproteinemic keratopathy, which identified chronic lymphocytic leukemia (CLL) as the potential systemic cause of the corneal findings.

Conclusions : Paraproteinemic keratopathies may present with phenotypic similarities to a variety of corneal dystrophies. Genetic testing, which is available for most corneal dystrophies, provides the clinician with a definitive means of differentiating between inherited and acquired disorders.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×